Trial intelligence / Profile preview

Meloxicam injection for postoperative orthopedic pain

CTR20202148Phase 2Completed

Sponsor
Hengrui Therapeutics
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of meloxicam in postoperative pain, sponsored by Hengrui Therapeutics. Started Oct 2020; status: completed.

02

Drugs

meloxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on CTR20202148.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20202148.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call